Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. - sprookjes - yvandenbroek - TriplyDB

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

http://www.wikidata.org/entity/Q37161554

about

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial Radiation Therapy after Radical Prostatectomy: Implications for Clinicians Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?FROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomy Nomograms in oncology: more than meets the eye Management of patients with biochemical recurrence after local therapy for prostate cancer External beam radiotherapy for localized prostate cancer Prostate cancer: ESMO Consensus Conference Guidelines 2012 A Urologist's Personal View of Prostate Cancer Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging Salvage radiotherapy after radical prostatectomy: prediction of biochemical outcomes Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer Prognostic outlier genes for enhanced prostate cancer treatment.Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists.Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial.Counseling patients about sexual health when considering post-prostatectomy radiation treatment.Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.Shared responsibility for treatment-related morbidity for prostate cancer Predicting 15-year prostate cancer specific mortality after radical prostatectomy.Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges.Identification of men with the highest risk of early disease recurrence after radical prostatectomy Critical review of prostate cancer predictive tools Androgen deprivation therapy for prostate cancer-review of indications in 2010 Role of radical prostatectomy for high-risk prostate cancer.Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group.Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.

P2860

Q24605205-12CFE21E-F8E7-43E4-B3ED-D9095E9E5792 Q26744531-7A4F4363-B9D5-4E86-879F-65EC5842BDE5 Q26747782-136BF383-61D5-41E1-B8CB-C30569FE891D Q26751574-6505ADD8-69F1-4782-B1F3-872BA5098A80 Q26765872-42170BC5-B196-44DB-990C-4F921D476C53 Q26774847-C7804921-C005-4DE5-8777-1B99C4607464 Q26777128-1014DF57-D5ED-4BD7-97DC-D02BB55EDDE2 Q26827690-951CE3F5-8E70-4D63-93EC-B0911263246E Q26830260-CD097510-74E0-4DFB-92A1-CC54F069900F Q26849220-E94B0F14-AB2F-4CBE-95B7-F4F19977F48B Q26853068-435161F2-8262-44C0-B19F-FA2E58B7355F Q27022847-8B15FA9E-507E-4489-9C70-F142703337B2 Q28072919-C2E3EC31-F2F7-49D8-AC6B-BF5272A27539 Q28074669-7A74C04E-53D7-4F9C-8160-8587DB116A60 Q28541306-A186D077-CD2B-47F3-A18D-ACDD677E497D Q28541950-31BA7774-1A53-451C-BF7B-6E062D1297C2 Q28543958-C843F46A-F3B6-4B81-8D28-D75ED92A003A Q28550860-5B300A04-01EB-4452-83C7-6886D70B57C8 Q30244674-A7BB1004-56A7-4A58-9C2A-DF1A31BB83AB Q30276626-F416F184-7FC6-4CC5-B2FA-A2D59871D4B6 Q30278648-020EE00B-5128-417E-AE02-837C01B39B9D Q30385364-69C98BD0-3C26-4E73-8BB7-55B0FEA4CE8B Q30586073-7B5BE218-5038-4741-9C5F-562CE227CDA2 Q33710312-E6EDEDD7-8AD4-4126-983E-0EFCDF941748 Q33754012-0CFB08C4-D9ED-47B1-B016-9927DE4FF3D1 Q33754017-60F10934-A092-46F2-A292-362F6B4539C7 Q33759725-5AA869F4-8697-4A19-9AAC-72B1D2F65D2D Q33761075-E04C33E2-7004-41A4-858F-08A1404565F5 Q33766462-1AE0249D-A45D-4F31-86AC-51C03720866F Q33825388-276369C0-6147-48DD-9229-20A53212A9BB Q34104562-E43CB9CF-BE22-4636-8E10-3D2CBFF94202 Q34111603-4AE034A2-2B3E-4C7F-8339-DB076EED8D27 Q34139187-29186DD7-5ACC-4CA1-9DDB-B9572D94743C Q34174451-0DF79B5F-6F96-4093-9D8E-42D192E92B38 Q34208260-3464BC49-035A-47CA-BD3F-5F3AE2712345 Q34325482-2F8431B8-88C9-495C-BFE8-5200D6A1FDE7 Q34437308-8DE5EF86-C66D-4DC6-9B67-C51E1A174A5C Q34462816-DF095A45-253F-4B16-8A94-56317419CF9D Q34637944-2EEB216A-D0A9-49FD-9F8D-F4F36E3C25EC Q34725046-CF98A665-0A58-4494-9CC2-B9CFB1D6ABFE

P2860

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

http://www.wikidata.org/entity/Q37161554

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predicting the outcome of salv ...... r after radical prostatectomy.

@en

Predicting the outcome of salv ...... r after radical prostatectomy.

@nl

type

label

Predicting the outcome of salv ...... r after radical prostatectomy.

@en

Predicting the outcome of salv ...... r after radical prostatectomy.

@nl

prefLabel

Predicting the outcome of salv ...... r after radical prostatectomy.

@en

Predicting the outcome of salv ...... r after radical prostatectomy.

@nl

P1433

Q37161554-3CC9473C-48F4-4B0F-8EE3-BADAE393D221

P1476

Q37161554-F5299986-97AD-400D-9CAD-A82C1EAEA302

P2093

Q37161554-015D1263-1462-41D3-9DF1-1A878D1CBDE8

Q37161554-0E9B89A2-CF7C-43AB-9EC0-409E5E701C1E

Q37161554-12F44877-FEA3-449F-B37D-20F8D95E1991

Q37161554-2A849F2D-B01C-4165-BF08-FAC5056EA55E

Q37161554-4ED690E6-1446-4010-87F6-2CC7C5D2F790

Q37161554-67CD2C36-DC33-4732-87D8-767A77D6B680

Q37161554-8A431C81-13C7-4200-8E14-FDA423330CC5

Q37161554-9E452637-44F1-4A86-92E6-841A82A07485

Q37161554-A4C84B5E-ED81-47C8-B558-DDCBD5D8F08D

Q37161554-A5D77A0D-18D1-47DA-B82F-28018C02A11C

P2860

Q37161554-02F6E23F-77F3-4E38-976F-789793D07BF4

Q37161554-1A943534-AC1D-400E-A065-5B587E56A3FB

Q37161554-2ADA1EAB-5AED-4DBE-A73E-8B04192CEB1C

Q37161554-3022B1C5-9343-494F-BCE5-02B1D908878A

Q37161554-31C31A32-5DD9-462A-8C58-7F7563284A48

Q37161554-32617A7F-5155-4DCD-9800-0320931A79A4

Q37161554-3E3AC54E-4789-4A52-888B-DB3F75AB1783

Q37161554-46C928A8-F5AD-4A1F-BD42-EFB26F99112D

Q37161554-64959100-FC64-444E-8DBD-D91E02DB1D45

Q37161554-662A7A2D-C68B-47AF-8B0F-E228DB9103EF

P304

Q37161554-8C4310BF-6EF8-4984-A755-CB32A6F4F33C

P31

Q37161554-A6DE6305-C8B5-4354-ACC3-08FC7F1EDADE

P356

Q37161554-14467634-D409-4FE9-BD08-F7F75C507CF7

P407

Q37161554-3402EE12-F629-40B9-9A95-1BE6EAFEEA78

P433

Q37161554-A2A2F7C0-3FFA-4CD2-96F8-8001C6E4EE12

P478

Q37161554-256A4F72-ED9E-42A0-9E36-11DBBF71B4BB

P50

Q37161554-7C7F05E2-7BB3-48B3-88F1-997AAEA5690C

Q37161554-97F24F85-477D-4E76-84E5-5E651BFFF6FC

P577

Q37161554-7B36118A-4DC2-4687-A598-B391A733ACE0

P5875

Q37161554-FECB8AEA-0D6F-4766-B7C9-964F1C6682F3

P698

Q37161554-22A8181D-0BDC-4636-BF1B-36EC851FA8F5

P921

Q37161554-DB40ACFC-E1E9-4BE9-A40A-BBB049012447

P932

Q37161554-51A247F2-1BF6-4FFC-96A8-D91F6B773472

P356

JCO.2006.08.9607

P1433

Journal of Clinical Oncology

P1476

Predicting the outcome of salv ...... r after radical prostatectomy.

@en

P2093

Alan Pollack

http://www.w3.org/2001/XMLSchema#string

Andrew J Stephenson

http://www.w3.org/2001/XMLSchema#string

Charles N Catton

http://www.w3.org/2001/XMLSchema#string

Claus G Roehrborn

http://www.w3.org/2001/XMLSchema#string

Daniel W Lin

http://www.w3.org/2001/XMLSchema#string

Deborah A Kuban

http://www.w3.org/2001/XMLSchema#string

Eric A Klein

http://www.w3.org/2001/XMLSchema#string

Howard M Sandler

http://www.w3.org/2001/XMLSchema#string

Jeff M Michalski

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Forman

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of progression after PSA elevation following radical prostatectomy.

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.

Evaluating the yield of medical tests.

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.

The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy.

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

P304

2035-2041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.08.9607

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell S Anscher

Michael J Zelefsky

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6318412

http://www.w3.org/2001/XMLSchema#string

P698

17513807

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2670394

http://www.w3.org/2001/XMLSchema#string